Table 3.

Average mean squared error (MSE) and empirical coverage simulation study results across all simulation settings and sets . Standard errors are presented in Table S5 of the supplementary material available at Biostatistics online

Metric	Method	E1	M1	E4	M4	E7	M7
Critical weeks ()
MSE*1000	GP	12.57	16.76	1.23	2.72	0.68	0.78
	SSVS	1.43	1.28	3.66	3.62	5.05	4.91
	CWVS Sep.	1.55	1.47	1.90	1.71	1.89	1.40
	CWVS LMC	1.79	2.23	1.17	1.92	0.76	0.68
Coverage	GP	0.66	0.60	0.90	0.85	0.96	0.95
	SSVS	0.92	1.00	0.93	0.94	0.90	0.91
	CWVS Sep.	0.90	1.00	0.96	0.99	0.97	0.99
	CWVS LMC	0.88	0.98	0.98	0.96	0.99	0.99
Bordering critical weeks ()
MSE*1000	GP	8.34	3.67	2.78	2.75	1.25	1.53
	SSVS	2.40	2.24	3.14	4.13	4.02	4.32
	CWVS Sep.	2.95	2.49	2.62	3.29	2.16	2.74
	CWVS LMC	2.96	2.51	2.21	2.48	1.31	1.67
Coverage	GP	0.72	0.93	0.76	0.82	0.88	0.87
	SSVS	0.96	0.97	0.96	0.91	0.94	0.92
	CWVS Sep.	0.92	0.95	0.96	0.94	0.90	0.88
	CWVS LMC	0.88	0.94	0.92	0.89	0.90	0.90
Non-critical, non-bordering critical weeks ()
MSE*1000	GP	2.25	2.71	0.55	0.61	0.45	0.50
	SSVS	1.64	2.04	2.32	2.36	2.92	2.98
	CWVS Sep.	1.86	2.25	1.23	1.47	0.96	1.27
	CWVS LMC	1.68	2.13	0.69	0.77	0.51	0.68
Coverage	GP	0.98	0.97	0.99	0.99	0.99	1.00
	SSVS	0.97	0.96	0.96	0.96	0.95	0.95
	CWVS Sep.	0.98	0.96	0.98	0.98	0.99	0.98
	CWVS LMC	0.94	0.95	1.00	0.99	0.99	0.99